New Pilot Study Using the FDA-Cleared Cionic Neural Sleeve Demonstrates Significant Improvements to Gait Impairments for Patients with Multiple Sclerosis
CIONIC , the neurotech inventor pioneering bionic clothing, today announced data showcasing the impact of the FDA-cleared Cionic Neural Sleeve as assistive technology for individuals experiencing difficulty walking due to multiple sclerosis (MS).
- CIONIC , the neurotech inventor pioneering bionic clothing, today announced data showcasing the impact of the FDA-cleared Cionic Neural Sleeve as assistive technology for individuals experiencing difficulty walking due to multiple sclerosis (MS).
- The real-world study, “Impact of the Cionic Neural Sleeve on Ankle Kinematics during Gait in Multiple Sclerosis,” evaluated the impact of CIONIC’s proprietary array-based stimulation approach to address neuromuscular walking challenges associated with foot drop, one of the most common gait impairments for individuals with neurologic conditions.
- Results of the study demonstrated significant improvements for both measures, and all participants experienced improvements to dorsiflexion at heel strike and reductions in inversion during swing when functional electrical stimulation from the Cionic Neural Sleeve activated the affected muscles.
- “These results show the tremendous power of our software-steered neuromodulation array and real-time adaptive algorithms to improve walking for individuals with MS.”
To learn more about the Cionic Neural Sleeve, visit cionic.com .